Condition
Organ Transplant Failure or Rejection
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Terminated1
Active Not Recruiting1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05609123Recruiting
Endothelial Glycocalyx Damage in Brain Death Organ Donors
NCT05148715Phase 2Active Not RecruitingPrimary
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
NCT02525510Not ApplicableCompleted
Deceased Organ Donor Interventions to Protect Kidney Graft Function
NCT04789213Completed
Mortality, Morbidity and Risk Factors of Liver Retransplantation
NCT03439995Not ApplicableTerminated
Goal of Open Lung Ventilation in Donors
Showing all 5 trials